217 related articles for article (PubMed ID: 23016931)
41. Ras/myc-transformed serum-free mouse embryo cells under simulated inflammatory and infectious conditions increase levels of nitric oxide and matrix metalloproteinase-9 without a direct association between them.
Yamaguchi H; Kidachi Y; Umetsu H; Ryoyama K
Mol Cell Biochem; 2007 Dec; 306(1-2):43-51. PubMed ID: 17660954
[TBL] [Abstract][Full Text] [Related]
42. Rhinovirus upregulates matrix metalloproteinase-2, matrix metalloproteinase-9, and vascular endothelial growth factor expression in nasal polyp fibroblasts.
Wang JH; Kwon HJ; Jang YJ
Laryngoscope; 2009 Sep; 119(9):1834-8. PubMed ID: 19572270
[TBL] [Abstract][Full Text] [Related]
43. The effect of amyloid associated proteins on the expression of genes involved in amyloid-β clearance by adult human astrocytes.
Mulder SD; Veerhuis R; Blankenstein MA; Nielsen HM
Exp Neurol; 2012 Jan; 233(1):373-9. PubMed ID: 22101005
[TBL] [Abstract][Full Text] [Related]
44. Involvement of matrix metalloproteinase-9 in amyloid-β 1-42-induced shedding of the pericyte proteoglycan NG2.
Schultz N; Nielsen HM; Minthon L; Wennström M
J Neuropathol Exp Neurol; 2014 Jul; 73(7):684-92. PubMed ID: 24918635
[TBL] [Abstract][Full Text] [Related]
45. Chemical imaging of evolving amyloid plaque pathology and associated Aβ peptide aggregation in a transgenic mouse model of Alzheimer's disease.
Michno W; Wehrli P; Meier SR; Sehlin D; Syvänen S; Zetterberg H; Blennow K; Hanrieder J
J Neurochem; 2020 Mar; 152(5):602-616. PubMed ID: 31605538
[TBL] [Abstract][Full Text] [Related]
46. Characterization of matrix metalloproteinase-2 and matrix metalloproteinase-9 and their inhibitors in equine granulosa cells in vivo and in vitro.
Sessions DR; Vick MM; Fitzgerald BP
J Anim Sci; 2009 Dec; 87(12):3955-66. PubMed ID: 19684269
[TBL] [Abstract][Full Text] [Related]
47. Macrophage-mediated degradation of beta-amyloid via an apolipoprotein E isoform-dependent mechanism.
Zhao L; Lin S; Bales KR; Gelfanova V; Koger D; Delong C; Hale J; Liu F; Hunter JM; Paul SM
J Neurosci; 2009 Mar; 29(11):3603-12. PubMed ID: 19295164
[TBL] [Abstract][Full Text] [Related]
48. Effect of biphasic electrical current stimulation on IL-1β-stimulated annulus fibrosus cells using in vitro microcurrent generating chamber system.
Kim JH; Choi H; Suh MJ; Shin JH; Hwang MH; Lee HM
Spine (Phila Pa 1976); 2013 Oct; 38(22):E1368-76. PubMed ID: 23823576
[TBL] [Abstract][Full Text] [Related]
49. Scavenger Receptor-A deficiency impairs immune response of microglia and astrocytes potentiating Alzheimer's disease pathophysiology.
Cornejo F; Vruwink M; Metz C; Muñoz P; Salgado N; Poblete J; Andrés ME; Eugenín J; von Bernhardi R
Brain Behav Immun; 2018 Mar; 69():336-350. PubMed ID: 29246456
[TBL] [Abstract][Full Text] [Related]
50. Neutralization of granulocyte macrophage colony-stimulating factor decreases amyloid beta 1-42 and suppresses microglial activity in a transgenic mouse model of Alzheimer's disease.
Manczak M; Mao P; Nakamura K; Bebbington C; Park B; Reddy PH
Hum Mol Genet; 2009 Oct; 18(20):3876-93. PubMed ID: 19617638
[TBL] [Abstract][Full Text] [Related]
51. [Expression and significance of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase in non-melanoma skin cancer].
Fu XR; Zhang C; Chen CY; Zhang L; Wang LX; Wang BH; Liu XY; Zhang MZ
Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):369-73. PubMed ID: 22883459
[TBL] [Abstract][Full Text] [Related]
52. The balance between MMP-2/-9 and TIMP-1/-2 is shifted towards MMP in renal cell carcinomas and can be further disturbed by hydrogen peroxide.
Hemmerlein B; Johanns U; Halbfass J; Böttcher T; Heuser M; Radzun HJ; Thelen P
Int J Oncol; 2004 May; 24(5):1069-76. PubMed ID: 15067327
[TBL] [Abstract][Full Text] [Related]
53. Matrix metalloproteinase-9 reduces islet amyloid formation by degrading islet amyloid polypeptide.
Aston-Mourney K; Zraika S; Udayasankar J; Subramanian SL; Green PS; Kahn SE; Hull RL
J Biol Chem; 2013 Feb; 288(5):3553-9. PubMed ID: 23229548
[TBL] [Abstract][Full Text] [Related]
54. HIV-1 gp120 upregulates matrix metalloproteinases and their inhibitors in a rat model of HIV encephalopathy.
Louboutin JP; Reyes BA; Agrawal L; Van Bockstaele EJ; Strayer DS
Eur J Neurosci; 2011 Dec; 34(12):2015-23. PubMed ID: 22092673
[TBL] [Abstract][Full Text] [Related]
55. Decreased homodimerization and increased TIMP-1 complexation of uteroplacental and uterine arterial matrix metalloproteinase-9 during hypertension-in-pregnancy.
Chen J; Ren Z; Zhu M; Khalil RA
Biochem Pharmacol; 2017 Aug; 138():81-95. PubMed ID: 28506758
[TBL] [Abstract][Full Text] [Related]
56. Delineating Amyloid Plaque Associated Neuronal Sphingolipids in Transgenic Alzheimer's Disease Mice (tgArcSwe) Using MALDI Imaging Mass Spectrometry.
Kaya I; Brinet D; Michno W; Syvänen S; Sehlin D; Zetterberg H; Blennow K; Hanrieder J
ACS Chem Neurosci; 2017 Feb; 8(2):347-355. PubMed ID: 27984697
[TBL] [Abstract][Full Text] [Related]
57. [Regulatory effects of inhaled steroids on expression of matrix metalloproteinase-9 and its inhibitor in asthmatic rats].
Qiao HM; Lu JR; Cheng HJ; Liu L; Ma QS; Fu WY; Zhao FX
Zhonghua Er Ke Za Zhi; 2005 Aug; 43(8):591-4. PubMed ID: 16191269
[TBL] [Abstract][Full Text] [Related]
58. N-truncated Aβ
Wirths O; Walter S; Kraus I; Klafki HW; Stazi M; Oberstein TJ; Ghiso J; Wiltfang J; Bayer TA; Weggen S
Alzheimers Res Ther; 2017 Oct; 9(1):80. PubMed ID: 28978359
[TBL] [Abstract][Full Text] [Related]
59. [Expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in the hepatocellular carcinomas].
Wei QY; Wu YQ; Fan SQ
Hunan Yi Ke Da Xue Xue Bao; 2003 Jun; 28(3):212-6. PubMed ID: 14653069
[TBL] [Abstract][Full Text] [Related]
60. [Reference ranges of matrix metalloproteinase-1, -2, -9 and tissue inhibitor of matrix metalloproteinases-1 concentrations in amniotic fluid in physiological pregnancy].
Korenovsky YV; Remneva OV
Biomed Khim; 2016; 62(1):96-8. PubMed ID: 26973196
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
